Relu® Reaches Medical Quality Standards with ISO13485 Certification

Relu, an OEM software provider in the dental industry, obtains ISO13485 certification from EU Notified Body Kiwa Dare. ISO13485 is the global quality standard for medical device companies.

Relu provides enterprise-grade AI for workflow automation in dental treatment software. They partner closely with leading dental software companies to make their software more valuable and user-friendly with AI. This ISO13485 certification will further increase the quality of Relu’s product, besides reducing the regulatory work of their partners when integrating AI in their medical device software. Relu takes this step to bring better AI innovation to both the dentist and the patient.

“This certification demonstrates our commitment to international quality and regulatory standards. Relu wants to build AI that people can trust.” says Holger Willems, Co-Founder & CEO at Relu.

“We’ve achieved ISO13485, underscoring our commitment to quality and safety. This certification reassures our global partners of our dedication to innovative AI solutions for implantology and orthodontics. It’s a clear mark of trust for all involved.” says Bindu Saran, Director at Relu and Former Global Head of Orthodontic Technology at Straumann Group.

SourceRelu

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.